Therefore, we suggest PPAR α/γ dual agonists, be considered potential agents that inhibit wrinkle formation and skin photoaging, and that MHY 966 be viewed as a potential lead compound for the development of anti-skin aging agents. Here, PPARA is linked to skin aging.